Xin Yinbang: the Prothioconazole technical was successfully registered in Brazil, and projects such as Saflufenacil are under way

 In May 2024, Shaoxing Shangyu Xin Yinbang Biochemical Co., LTD. (hereinafter referred to as "Xin Yinbang") Prothioconazole was registered in Brazil

It is reported that Xin Yinbang has obtained China pesticide registration certificate and production license for this product, and has also obtained China ICAMA registration certificate for 40% Prothioconazole ·Tebuconazole SC.

Prothioconazole is an efficient broad-spectrum triazolthione fungicide. Its mechanism of action is to inhibit the 14-position demethylation of lanolin, the precursor of sterol in fungi. This fungicide has remarkable control effect on various fungal diseases of cereal crops, including powdery mildew, scab, sheath blight and rust. In addition, Prothioconazole can effectively control soil-borne diseases of rape and peanut, as well as major leaf diseases such as gray mold, brown spot and black spot. Due to its high activity, broad spectrum and safety, Prothioconazole is widely used in a variety of crops worldwide, such as wheat, soybean, rape, rice, peanut and sugar beet. In particular, 40% Prothioconazole ·Tebuconazole SC. has outstanding control effect on wheat scab, powdery mildew and rust, and can achieve multiple prevention with one drug.

The successful registration of Xin Yinbang in the Brazilian market will help the company's business development in the region, and Brazil will also become the focus of Xin Yinbang's development market. The Company will continue to increase its investment in the international registration of Methoxyfenozide, Bifenazate, Hymexazol, and Saflufenacil products, especially in countries and regions such as the United States, Canada, the European Union and Brazil.

As a national high-tech enterprise, Xin Yinbang has always adhered to the purpose of "serving agriculture and creating green" and is committed to innovation and improvement of the agrochemical industry. The company's existing production capacity includes 400 tons/year of Methoxyfenozide, 1,000 tons/year of Prothioconazole, 1,750 tons/year of Bifenazate and 1,000 tons/year of Hymexazol. At the same time, Xin Yinbang is also actively developing new products, such as Bixafen, Trifloxystrobin, Saflufenacil and Cyflumetofen, to meet the needs of domestic and foreign customers.